ArticleJMA journal2026
Changes in Oral Analgesic Prescribing in Japan between Fiscal Year 2014 and Fiscal Year 2022: A Nationwide Analysis Using Open Data from the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
Article in JMA journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Nonsteroidal anti-inflammatory drugs (NSAIDs) have traditionally been central to pharmacological pain management in Japan, but population aging and increased use of mechanism-based analgesics may be changing prescribing patterns. We compared oral analgesic prescribing between fiscal year (FY) 2014 and FY2022 using nationwide claims-based open data, focusing on age and sex differences. Methods: We analyzed aggregated prescription volumes from the 1st and 9th editions of the National Database of Health Insurance Claims and Specific Health Checkups of Japan Open Data for FY2014 (April 2014-March 2015) and FY2022 (April 2022-March 2023). Analgesics were grouped as acetaminophen, NSAIDs, cyclooxygenase-2 selective inhibitors, weak opioids, duloxetine, neuropathic pain medications, and neurotropin. We calculated population-based prescription volume rates (per 1,000 population) using official population estimates and summarized patterns by sex and age group (<20, 20-64, ≥65 years). We also calculated within-age-group composition (percent share). Poisson regression with log(population) offset estimated incidence rate ratios (IRRs) comparing FY2022 versus FY2014 using robust standard errors; NSAID IRRs were further examined by age-sex strata. Results: Total prescription volume increased from 3.69 × 10 Conclusions: Oral analgesic prescribing in Japan increased substantially between FY2014 and FY2022, alongside age-specific shifts away from NSAIDs toward acetaminophen and neuropathic pain medications, particularly among older adults.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.